Potassium Channels in Parkinson’s Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment
Open Access
- 14 March 2023
- journal article
- review article
- Published by Elsevier in Pharmacological Reviews
- Vol. 75 (4) , 758-788
Abstract
Parkinson9s disease (PD) is a neurodegenerative disorder characterized by selective loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) region of the midbrain. The loss of neurons results in a subsequent reduction of dopamine in the striatum, which underlies the core motor symptoms of PD. To date, there are no effective treatments to stop, slow, or reverse the pathological progression of dopaminergic neurodegeneration. This unfortunate predicament is because of the current early stages in understanding the biological targets and pathways involved in PD pathogenesis. Ion channels have become emerging targets for new therapeutic development for PD due to their essential roles in neuronal function and neuroinflammation. Potassium channels are the most prominent ion channel family and have been shown to be critically important in PD pathology because of their roles in modulating neuronal excitability, neurotransmitter release, synaptic transmission, and neuroinflammation. In this review, members of the subfamilies of voltage-gated K+ channels, inward rectifying K+ channels, and Ca2+-activated potassium channels are described. Evidence of the role of these channels in PD aetiology is discussed together with the latest views on related pathological mechanisms and their potential as biological targets for developing neuroprotective drugs for PD. Significance Statement Parkinson9s disease (PD) is the second most common neurodegenerative disorder, featuring progressive degeneration of dopaminergic neurons in the midbrain. It is a multifactorial disease involving multiple risk factors and complex pathobiological mechanisms. Mounting evidence suggests that ion channels play vital roles in the pathogenesis and progression of PD by regulating neuronal excitability and immune cell function. Therefore, they have become "hot" biological targets for PD, as demonstrated by multiple clinical trials of drug candidates targeting ion channels for PD therapy.Keywords
This publication has 527 references indexed in Scilit:
- Selective Activation of KCa3.1 and CRAC Channels by P2Y2 Receptors Promotes Ca2+ Signaling, Store Refilling and Migration of Rat Microglial CellsPLOS ONE, 2013
- Structure–activity relationship exploration of Kv1.3 blockers based on diphenoxylateBioorganic & Medicinal Chemistry Letters, 2012
- Living on the edge with too many mouths to feed: Why dopamine neurons dieMovement Disorders, 2012
- Association study of the KCNJ3 gene as a susceptibility candidate for schizophrenia in the Chinese populationHuman Genetics, 2011
- Effect of Sensor Domain Mutations on the Properties of Voltage-Gated Ion Channels: Molecular Dynamics Studies of the Potassium Channel Kv1.2Biophysical Journal, 2010
- High-Resolution Orientation and Depth of Insertion of the Voltage-Sensing S4 Helix of a Potassium Channel in Lipid BilayersJournal of Molecular Biology, 2010
- The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: Clinical relevanceExperimental Neurology, 2010
- Molecular mechanisms of BK channel activationCellular and Molecular Life Sciences, 2008
- Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s diseaseClinical Neuroscience Research, 2006
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003